DXB Media thread., page-14

First 14 Last

Share
Profile

Follow
Owl vs Fox

6,434 Posts.

5274

01/02/24

12:52

Post #: 72183336
Share
Originally posted by ExtraPace: ↑

Hey Owl vs Fox

I missed your re-post on my thread. Yes converting options is good move but this can easily go higher >$1.0 post mid-March result but I wouldn't be selling anytime soon as I'm counting high efficacy (80%) on clinical trial but this will also back-test eGFR result (of course it is double blinded which may not be available to us).

The China NMPA has already endorsed trial for ACTION-3 phase 2 (refer to last announcement-Clinical sites on mainland China are intended for Part 2 of the FSGS ACTION3 Phase 3 clinical trial currently recruiting in 11 other countries). The post mid-march result (I'm guessing end or March or early April) is pivotal in the sense that DXB will potentially receive additional payment from Advanz to secure commercialisation of DXB 200 and almost certain to get 2 additional commercial deals from China and US. This will also entail

No Capital raise requirement to complete Phase 2 and 3 of ACTION-3
Much better commercial deals in US and China compared to Advanz
R & D payment reimbursement
SP appreciation of many folds

DXB investment could be life changing as it is targeting Billion Dollar Market with no alternative medication available atm, but DYOR before any buy or sell and trust your investment. I'm not financial advisor.

Expand

Hey Extra, I think I made it clear I wouldn’t be selling any converted oppies. I’m retail, you know one of those Mum & Dad investors that’s learnt along the way as to how the Market works, lol. My occupation helps me in my investments but more so understanding research.
DXB Price at posting: 22.0¢ Sentiment: Buy Disclosure: Held
9 Upvote

0 Great analysis

Reply

Top Stories

Week 3 CY26, wrapped: Metals surge, EU troops in Greenland, BHP@$50? and Powell's next test

Listen: HotCopper Wire Podcast 038 – Trump vs. Powell, black gold, and sneakers

DealRoom is expanding: Your global gateway to capital-raising investments

AFP

Fridge-free drugs, global markets: How AFT are targeting a $6 billion opportunity

AVM

Advance Metals hits 'world class' high-grade silver at depth as Yoquivo grows

There are more pages in this discussion • 17 more messages in this thread...

First 14 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 53.5¢		Change -0.005(0.93%)		Mkt cap ! $324.2M

Open	High	Low	Volume
53.5¢	54.5¢	53.5¢	547.4K

Buyers (Bids)

Vol.	Price($)
38623	53.5¢

Sellers (Offers)

Price($)	Vol.
54.0¢	23225

Last trade - 11.59am 19/01/2026 (20 minute delay)

DXB (ASX) Chart

DXB Media thread., page-14

Week 3 CY26, wrapped: Metals surge, EU troops in Greenland, BHP@$50? and Powell's next test

Listen: HotCopper Wire Podcast 038 – Trump vs. Powell, black gold, and sneakers

DealRoom is expanding: Your global gateway to capital-raising investments

Fridge-free drugs, global markets: How AFT are targeting a $6 billion opportunity

Advance Metals hits 'world class' high-grade silver at depth as Yoquivo grows

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

DXB Media thread., page-14

Top Stories

Week 3 CY26, wrapped: Metals surge, EU troops in Greenland, BHP@$50? and Powell's next test

Listen: HotCopper Wire Podcast 038 – Trump vs. Powell, black gold, and sneakers

DealRoom is expanding: Your global gateway to capital-raising investments

Fridge-free drugs, global markets: How AFT are targeting a $6 billion opportunity

Advance Metals hits 'world class' high-grade silver at depth as Yoquivo grows

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News